{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:47:40Z","timestamp":1793227660288,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University"},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"crossref","award":["NRCT5-RGJ63001-007"],"award-info":[{"award-number":["NRCT5-RGJ63001-007"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Second Century Fund (C2F), Chulalongkorn University"},{"DOI":"10.13039\/100000057","name":"National Institute for General Medical Sciences","doi-asserted-by":"crossref","award":["P20 GM125503"],"award-info":[{"award-number":["P20 GM125503"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Thailand Science research and Innovation Fund Chulalongkorn University","award":["HEA663000043"],"award-info":[{"award-number":["HEA663000043"]}]},{"name":"Fundamental Fund 2022"},{"name":"Program Management Unit for Human Resources & Institutional Development, Research and Innovation","award":["(B36G660010)"],"award-info":[{"award-number":["(B36G660010)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Long-term effect of Direct-acting antivirals (DAAs) on gut microbiota, short-chain fatty acids (SCFAs) and microbial translocation in patients with hepatitis C virus (HCV) infection who achieve sustained virological response (SVR) were limited. A longitudinal study of 50 patients with HCV monoinfection and 19 patients with HCV\/HIV coinfection received DAAs were conducted. Fecal specimens collected at baseline and at week 72 after treatment completion (FUw72) were analyzed for 16S rRNA sequencing and the butyryl-CoA:acetateCoA transferase (BCoAT) gene expression using real-time PCR. Plasma lipopolysaccharide binding protein (LBP) and intestinal fatty acid binding protein (I-FABP) were quantified by ELISA assays. SVR rates in mono- and coinfected patients were comparable (94% vs. 100%). The improvement of gut dysbiosis and microbial translocation was found in responders but was not in non-responders. Among responders, significant restoration of alpha-diversity, BCoAT and LBP were observed in HCV patients with low-grade fibrosis (F0\u2013F1), while HCV\/HIV patients exhibited partial improvement at FUw72. I-FABP did not decline significantly in responders. Treatment induced microbiota changes with increasing abundance of SCFAs-producing bacteria, including <jats:italic>Blautia, Fusicatenibacter, Subdoligranulum and Bifidobacterium<\/jats:italic>. In conclusion, long-term effect of DAAs impacted the restoration of gut dysbiosis and microbial translocation. However, early initiation of DAAs required for an alteration of gut microbiota, enhanced SCFAs-producing bacteria, and could reduce HCV-related complications.<\/jats:p>","DOI":"10.1038\/s41598-023-41664-7","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T10:01:59Z","timestamp":1693648919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection"],"prefix":"10.1038","volume":"13","author":[{"given":"Natthaya","family":"Chuaypen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thananya","family":"Jinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intawat","family":"Nookaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pisit","family":"Tangkijvanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"key":"41664_CR1","doi-asserted-by":"publisher","unstructured":"Spearman, C. W., Dusheiko, G. M., Hellard, M. & Sonderup, M. Hepatitis C. Lancet 394, 1451\u20131466, https:\/\/doi.org\/10.1016\/S0140-6736(19)32320-7 (2019).","DOI":"10.1016\/S0140-6736(19)32320-7"},{"key":"41664_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","volume":"14","author":"AP Thrift","year":"2017","unstructured":"Thrift, A. P., El-Serag, H. B. & Kanwal, F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat. Rev. Gastroenterol. Hepatol. 14, 122\u2013132. https:\/\/doi.org\/10.1038\/nrgastro.2016.176 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"41664_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41575-022-00608-8","volume":"19","author":"MP Manns","year":"2022","unstructured":"Manns, M. P. & Maasoumy, B. Breakthroughs in hepatitis C research: From discovery to cure. Nat. Rev. Gastroenterol. Hepatol. 19, 533\u2013550. https:\/\/doi.org\/10.1038\/s41575-022-00608-8 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"41664_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jhep.2019.07.021","volume":"71","author":"C Rossi","year":"2019","unstructured":"Rossi, C. et al. Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations. J. Hepatol. 71, 1116\u20131125. https:\/\/doi.org\/10.1016\/j.jhep.2019.07.021 (2019).","journal-title":"J. Hepatol."},{"key":"41664_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi, A. et al. The gut-liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15, 397\u2013411. https:\/\/doi.org\/10.1038\/s41575-018-0011-z (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"41664_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1055\/s-0037-1602763","volume":"37","author":"BC Davis","year":"2017","unstructured":"Davis, B. C. & Bajaj, J. S. The human gut microbiome in liver diseases. Semin. Liver Dis. 37, 128\u2013140. https:\/\/doi.org\/10.1055\/s-0037-1602763 (2017).","journal-title":"Semin. Liver Dis."},{"key":"41664_CR7","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","volume":"65","author":"H Tilg","year":"2016","unstructured":"Tilg, H., Cani, P. D. & Mayer, E. A. Gut microbiome and liver diseases. Gut 65, 2035\u20132044. https:\/\/doi.org\/10.1136\/gutjnl-2016-312729 (2016).","journal-title":"Gut"},{"key":"41664_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/cid\/ciy205","volume":"67","author":"T Inoue","year":"2018","unstructured":"Inoue, T. et al. Gut dysbiosis associated with hepatitis C virus infection. Clin. Infect. Dis. 67, 869\u2013877. https:\/\/doi.org\/10.1093\/cid\/ciy205 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"41664_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/liv.13485","volume":"38","author":"B Heidrich","year":"2018","unstructured":"Heidrich, B. et al. Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls. Liver Int. 38, 50\u201358. https:\/\/doi.org\/10.1111\/liv.13485 (2018).","journal-title":"Liver Int."},{"key":"41664_CR10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1053\/j.gastro.2011.06.063","volume":"141","author":"NG Sandler","year":"2011","unstructured":"Sandler, N. G. et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 141, 1220\u20131230. https:\/\/doi.org\/10.1053\/j.gastro.2011.06.063 (2011).","journal-title":"Gastroenterology"},{"key":"41664_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz255","author":"MS Moon","year":"2019","unstructured":"Moon, M. S. et al. Bacterial translocation and host immune activation in chronic hepatitis C infection. Open Forum Infect. Dis. https:\/\/doi.org\/10.1093\/ofid\/ofz255 (2019).","journal-title":"Open Forum Infect. Dis."},{"key":"41664_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/apt.15004","volume":"48","author":"FR Ponziani","year":"2018","unstructured":"Ponziani, F. R. et al. Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis. Aliment. Pharmacol. Ther. 48, 1301\u20131311. https:\/\/doi.org\/10.1111\/apt.15004 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"41664_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejim.2019.06.005","volume":"67","author":"P Perez-Matute","year":"2019","unstructured":"Perez-Matute, P. et al. Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients. Eur. J. Intern. Med. 67, 47\u201358. https:\/\/doi.org\/10.1016\/j.ejim.2019.06.005 (2019).","journal-title":"Eur. J. Intern. Med."},{"key":"41664_CR14","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/infdis\/jiab094","volume":"224","author":"N Chuaypen","year":"2021","unstructured":"Chuaypen, N. et al. Improvement of gut diversity and composition after direct-acting antivirals in hepatitis C virus-infected patients with or without human immunodeficiency virus coinfection. J. Infect. Dis. 224, 1410\u20131421. https:\/\/doi.org\/10.1093\/infdis\/jiab094 (2021).","journal-title":"J. Infect. Dis."},{"key":"41664_CR15","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/apt.14994","volume":"48","author":"B Lattanzi","year":"2018","unstructured":"Lattanzi, B. et al. Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients. Aliment. Pharmacol. Ther. 48, 1146\u20131155. https:\/\/doi.org\/10.1111\/apt.14994 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"41664_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/17512433.2018.1447923","volume":"11","author":"FR Ponziani","year":"2018","unstructured":"Ponziani, F. R. et al. Treatment of early stage chronic hepatitis C virus infection. Expert. Rev. Clin. Pharmacol. 11, 519\u2013524. https:\/\/doi.org\/10.1080\/17512433.2018.1447923 (2018).","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"41664_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hep.31700","volume":"74","author":"F Wellhoner","year":"2021","unstructured":"Wellhoner, F. et al. Eradication of chronic HCV infection: Improvement of dysbiosis only in patients without liver cirrhosis. Hepatology 74, 72\u201382. https:\/\/doi.org\/10.1002\/hep.31700 (2021).","journal-title":"Hepatology"},{"key":"41664_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal, A., Valdes, A. M. & Menni, C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes 13, 1\u201324. https:\/\/doi.org\/10.1080\/19490976.2021.1897212 (2021).","journal-title":"Gut Microbes"},{"key":"41664_CR19","doi-asserted-by":"publisher","first-page":"590685","DOI":"10.3389\/fimmu.2020.590685","volume":"11","author":"Q Yang","year":"2020","unstructured":"Yang, Q., Ouyang, J., Sun, F. & Yang, J. Short-chain fatty acids: A soldier fighting against inflammation and protecting from tumorigenesis in people with diabetes. Front Immunol. 11, 590685. https:\/\/doi.org\/10.3389\/fimmu.2020.590685 (2020).","journal-title":"Front Immunol."},{"key":"41664_CR20","doi-asserted-by":"publisher","first-page":"567654","DOI":"10.3389\/fmicb.2020.567654","volume":"11","author":"X Dai","year":"2020","unstructured":"Dai, X. et al. Microbial metabolites: Critical regulators in NAFLD. Front Microbiol. 11, 567654. https:\/\/doi.org\/10.3389\/fmicb.2020.567654 (2020).","journal-title":"Front Microbiol."},{"key":"41664_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fmicb.2016.00925","volume":"7","author":"A O'Callaghan","year":"2016","unstructured":"O\u2019Callaghan, A. & van Sinderen, D. Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol. 7, 925. https:\/\/doi.org\/10.3389\/fmicb.2016.00925 (2016).","journal-title":"Front Microbiol."},{"key":"41664_CR22","doi-asserted-by":"publisher","first-page":"8770","DOI":"10.1038\/s41598-017-09395-8","volume":"7","author":"D Fang","year":"2017","unstructured":"Fang, D. et al. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota. Sci. Rep. 7, 8770. https:\/\/doi.org\/10.1038\/s41598-017-09395-8 (2017).","journal-title":"Sci. Rep."},{"key":"41664_CR23","doi-asserted-by":"publisher","first-page":"100676","DOI":"10.1016\/j.aohep.2022.100676","volume":"27","author":"W Shu","year":"2022","unstructured":"Shu, W., Shanjian, C., Jinpiao, L. & Qishui, O. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis. Ann. Hepatol. 27, 100676. https:\/\/doi.org\/10.1016\/j.aohep.2022.100676 (2022).","journal-title":"Ann. Hepatol."},{"key":"41664_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13099-022-00501-4","volume":"14","author":"Z Ashour","year":"2022","unstructured":"Ashour, Z. et al. Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load. Gut Pathog. 14, 25. https:\/\/doi.org\/10.1186\/s13099-022-00501-4 (2022).","journal-title":"Gut Pathog."},{"key":"41664_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky, J. et al. Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders. Nat. Rev. Gastroenterol. Hepatol. 17, 279\u2013297. https:\/\/doi.org\/10.1038\/s41575-020-0269-9 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"41664_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1849998","volume":"12","author":"M Van Hul","year":"2020","unstructured":"Van Hul, M. et al. From correlation to causality: The case of Subdoligranulum. Gut Microbes 12, 1\u201313. https:\/\/doi.org\/10.1080\/19490976.2020.1849998 (2020).","journal-title":"Gut Microbes"},{"key":"41664_CR27","doi-asserted-by":"publisher","first-page":"717925","DOI":"10.3389\/fnut.2021.717925","volume":"8","author":"T Vanuytsel","year":"2021","unstructured":"Vanuytsel, T., Tack, J. & Farre, R. The role of intestinal permeability in gastrointestinal disorders and current methods of evaluation. Front Nutr. 8, 717925. https:\/\/doi.org\/10.3389\/fnut.2021.717925 (2021).","journal-title":"Front Nutr."},{"key":"41664_CR28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/apt.16602","volume":"54","author":"B Simbrunner","year":"2021","unstructured":"Simbrunner, B., Trauner, M. & Reiberger, T. Review article: Therapeutic aspects of bile acid signalling in the gut-liver axis. Aliment. Pharmacol. Ther. 54, 1243\u20131262. https:\/\/doi.org\/10.1111\/apt.16602 (2021).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"41664_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11904-020-00537-8","volume":"18","author":"JH Sim","year":"2021","unstructured":"Sim, J. H., Mukerji, S. S., Russo, S. C. & Lo, J. Gastrointestinal dysfunction and HIV comorbidities. Curr. HIV\/AIDS Rep. 18, 57\u201362. https:\/\/doi.org\/10.1007\/s11904-020-00537-8 (2021).","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"Suppl 2","key":"41664_CR30","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1093\/infdis\/jiw258","volume":"214","author":"JC Mudd","year":"2016","unstructured":"Mudd, J. C. & Brenchley, J. M. Gut mucosal barrier dysfunction, microbial dysbiosis, and their role in HIV-1 disease progression. J. Infect. Dis. 214(Suppl 2), S58\u2013S66. https:\/\/doi.org\/10.1093\/infdis\/jiw258 (2016).","journal-title":"J. Infect. Dis."},{"key":"41664_CR31","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41467-021-21472-1","volume":"12","author":"S Serrano-Villar","year":"2021","unstructured":"Serrano-Villar, S. et al. Fecal microbiota transplantation in HIV: A pilot placebo-controlled study. Nat. Commun. 12, 1139. https:\/\/doi.org\/10.1038\/s41467-021-21472-1 (2021).","journal-title":"Nat. Commun."},{"key":"41664_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2016160209","volume":"281","author":"AT Trout","year":"2016","unstructured":"Trout, A. T. et al. Liver stiffness measurements with MR elastography: Agreement and repeatability across imaging systems, field strengths, and pulse sequences. Radiology 281, 793\u2013804. https:\/\/doi.org\/10.1148\/radiol.2016160209 (2016).","journal-title":"Radiology"},{"key":"41664_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2463\/mrms.11.291","volume":"11","author":"S Ichikawa","year":"2012","unstructured":"Ichikawa, S. et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn. Reson. Med. Sci. 11, 291\u2013297. https:\/\/doi.org\/10.2463\/mrms.11.291 (2012).","journal-title":"Magn. Reson. Med. Sci."},{"issue":"3","key":"41664_CR34","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet 17(3), 2011. https:\/\/doi.org\/10.14806\/ej.17.1.200 (2011).","journal-title":"EMBnet j."},{"key":"41664_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583. https:\/\/doi.org\/10.1038\/nmeth.3869 (2016).","journal-title":"Nat. Methods"},{"key":"41664_CR36","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2012","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596. https:\/\/doi.org\/10.1093\/nar\/gks1219 (2012).","journal-title":"Nucleic Acids Res."},{"key":"41664_CR37","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8, e61217. https:\/\/doi.org\/10.1371\/journal.pone.0061217 (2013).","journal-title":"PLoS One"},{"key":"41664_CR38","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/aem.02561-06","volume":"73","author":"P Louis","year":"2007","unstructured":"Louis, P. & Flint, H. J. Development of a semiquantitative degenerate real-time PCR-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl. Environ. Microbiol. 73, 2009\u20132012. https:\/\/doi.org\/10.1128\/aem.02561-06 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"41664_CR39","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2013","unstructured":"Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res 41, e1. https:\/\/doi.org\/10.1093\/nar\/gks808 (2013).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41664-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:11:26Z","timestamp":1700421086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41664"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41664-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14413"}}